Photodynamic Therapies
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
66
NCT05919238
Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma
Phase: Phase 1
Role: Lead Sponsor
Start: May 15, 2024
Completion: Oct 30, 2026
NCT05918783
Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer
Start: May 28, 2025
Completion: Dec 30, 2028
Loading map...